Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vectomega distribution deal

This article was originally published in The Tan Sheet

Executive Summary

New Chapter and EuroPharma have inked an agreement that appoints New Chapter as the exclusive distributor of the Green Bay, Wisc.-based ingredient supplier's Vectomega omega-3 phospholipid complex for the health food/natural product retail channel, the firms announce Sept. 8. The ingredient is a "natural marine complex" that is "50 times more absorbable across cellular membranes than other DHA/EPA products," according to EuroPharma (1"The Tan Sheet" July 17, 2006, p. 6). Vectomega delivers DHA and EPA in "their natural phospholipid form" without artificial modifications, a trait that fits with New Chapter's principle of providing whole-food products and supplements, the Brattleboro, Vt.-based manufacturer states. EuroPharma President Terry Lemerond and the principle scientists will promote the product with personal endorsements, "including public appearances at trade shows and industry events," and possible television and radio appearances, the firms state. Additional details about the agreement were not disclosed...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099769

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel